Bacteremia and MR-proANP changes in mild community-acquired pneumonia

References

• Bordón J, Peyrani P, Brock GN, Blasi F, Rello J, File T, Ramirez J; CAPO Study Group. (2008). The presence of pneumococcal bacteremia does not influence clinical outcomes in patients with community-acquired pneumonia: results from the Community-Acquired Pneumonia Organization (CAPO) International Cohort study. Chest 133:618–624.
   PubMed Web of Science ®Google Scholar
• Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig LM, Lijmer JG, Moher D, Rennie D, de Vet HC; Standards for Reporting of Diagnostic Accuracy. (2003). Towards complete and accurate reporting of studies of diagnostic accuracy: The STARD Initiative. Ann Intern Med 138:40–44.
   PubMed Web of Science ®Google Scholar
• Brown PD, Lerner SA. (1998). Community-acquired pneumonia. Lancet 352:1295–1302.
   PubMed Web of Science ®Google Scholar
• Claessens YE, Mathevon T, Kierzek G, Grabar S, Jegou D, Batard E, Loyer C, Davido A, Hausfater P, Robert H, Lavagna-Perez L, Bernot B, Plaisance P, Leroy C, Renaud B. (2010). Accuracy of C-reactive protein, procalcitonin, and mid-regional pro-atrial natriuretic peptide to guide site of care of community-acquired pneumonia. Intensive Care Med 36:799–809.
   PubMed Web of Science ®Google Scholar
• de Kruif MD, Lemaire LC, Giebelen IA, Struck J, Morgenthaler NG, Papassotiriou J, Elliott PJ, van der Poll T. (2008). The influence of corticosteroids on the release of novel biomarkers in human endotoxemia. Intensive Care Med 34:518–522.
   PubMed Web of Science ®Google Scholar
• DeLong ER, DeLong DM, Clarke-Pearson DL. (1988). Comparing the areas under two or more correlated receiver operating characteristic curves: A nonparametric approach. Biometrics 44:837–845.
   PubMed Web of Science ®Google Scholar
• Guinard-Barbier S, Grabar S, Chenevier-Gobeaux C, Quinquis L, Schmidt J, Kierzek G, Guérin S, Hausfater P, Bernot B, Brun P, Gayet A, Casalino E, Andreotti C, Renaud B, Claessens YE. (2011). Is mid-regional pro-atrial natriuretic peptide (MRproANP) an accurate marker of bacteremia in pyelonephritis? Biomarkers 16:355–363.
   PubMed Web of Science ®Google Scholar
• Huang DT, Weissfeld LA, Kellum JA, Yealy DM, Kong L, Martino M, Angus DC; GenIMS Investigators. (2008). Risk prediction with procalcitonin and clinical rules in community-acquired pneumonia. Ann Emerg Med 52:48–58.e2.
   Google Scholar
• Krüger S, Ewig S, Kunde J, Hartmann O, Suttorp N, Welte T; CAPNETZ Study Group. (2010). Pro-atrial natriuretic peptide and pro-vasopressin for predicting short-term and long-term survival in community-acquired pneumonia: results from the German Competence Network CAPNETZ. Thorax 65:208–214.
   PubMed Web of Science ®Google Scholar
• Krüger S, Ewig S, Marre R, Papassotiriou J, Richter K, von Baum H, Suttorp N, Welte T; CAPNETZ Study Group. (2008). Procalcitonin predicts patients at low risk of death from community-acquired pneumonia across all CRB-65 classes. Eur Respir J 31:349–355.
   PubMed Web of Science ®Google Scholar
• Lisboa T, Blot S, Waterer GW, Canalis E, de Mendoza D, Rodriguez A, Rello J; Community-Acquired Pneumonia Intensive Care Units Study Investigators. (2009). Radiologic progression of pulmonary infiltrates predicts a worse prognosis in severe community-acquired pneumonia than bacteremia. Chest 135:165–172.
   Google Scholar
• Lisboa T, Seligman R, Diaz E, Rodriguez A, Teixeira PJ, Rello J. (2008). C-reactive protein correlates with bacterial load and appropriate antibiotic therapy in suspected ventilator-associated pneumonia. Crit Care Med 36:166–171.
   PubMed Web of Science ®Google Scholar
• Maeshiro K, Takamori S, Mifune H, Matsuo T, Kimura NY, Honda J, Shirouzu K. (2008). Changes in A-type natriuretic peptide and its receptors induced by a neutral endopeptidase inhibitor in a rat model of sepsis. Surg Today 38:130–134.
   Google Scholar
• Maisel A, Mueller C, Nowak R, Peacock WF, Landsberg JW, Ponikowski P, Mockel M, Hogan C, Wu AH, Richards M, Clopton P, Filippatos GS, Di Somma S, Anand I, Ng L, Daniels LB, Neath SX, Christenson R, Potocki M, McCord J, Terracciano G, Kremastinos D, Hartmann O, von Haehling S, Bergmann A, Morgenthaler NG, Anker SD. (2010). Mid-region pro-hormone markers for diagnosis and prognosis in acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial. J Am Coll Cardiol 55:2062–2076.
   PubMed Web of Science ®Google Scholar
• Marrie TJ, Low DE, De Carolis E; Canadian Community-Acquired Pneumonia Investigators. (2003). A comparison of bacteremic pneumococcal pneumonia with nonbacteremic community-acquired pneumonia of any etiology–results from a Canadian multicentre study. Can Respir J 10:368–374.
   Google Scholar
• Masiá M, Papassotiriou J, Morgenthaler NG, Hernández I, Shum C, Gutiérrez F. (2007). Midregional pro-A-type natriuretic peptide and carboxy-terminal provasopressin may predict prognosis in community-acquired pneumonia. Clin Chem 53:2193–2201.
   PubMed Web of Science ®Google Scholar
• Morgenthaler NG, Struck J, Christ-Crain M, Bergmann A, Müller B. (2005). Pro-atrial natriuretic peptide is a prognostic marker in sepsis, similar to the APACHE II score: an observational study. Crit Care 9:R37–R45.
   PubMed Web of Science ®Google Scholar
• Müller B, Süess E, Schuetz P, Müller C, Bingisser R, Bergmann A, Stolz D, Tamm M, Morgenthaler NG, Christ-Crain M. (2006). Circulating levels of pro-atrial natriuretic peptide in lower respiratory tract infections. J Intern Med 260:568–576.
   PubMed Web of Science ®Google Scholar
• Müller F, Christ-Crain M, Bregenzer T, Krause M, Zimmerli W, Mueller B, Schuetz P; ProHOSP Study Group. (2010). Procalcitonin levels predict bacteremia in patients with community-acquired pneumonia: a prospective cohort trial. Chest 138:121–129.
   PubMed Web of Science ®Google Scholar
• Prat C, Lacoma A, Dominguez J, Papassotiriou J, Morgenthaler NG, Andreo F, Tudela P, Ruiz-Manzano J, Ausina V. (2007). Midregional pro-atrial natriuretic peptide as a prognostic marker in pneumonia. J Infect 55:400–407.
   PubMed Web of Science ®Google Scholar
• van Langevelde P, Joop K, van Loon J, Frölich M, Groeneveld PH, Westendorp RG, van Dissel JT. (2000). Endotoxin, cytokines, and procalcitonin in febrile patients admitted to the hospital: identification of subjects at high risk of mortality. Clin Infect Dis 31:1343–1348.
   PubMed Web of Science ®Google Scholar